Intel-backed cardiovascular diagnostics firm CardioDx raises $58m in a venture round joined by Temasek and existing investors.
Cardiovascular genomic diagnostics company CardioDx has raised $58m in its latest venture round. The round saw Singapore-based investment firm Temasek join CardioDx’s previous investors; which include Intel, RU-COM, General Electric, and DAG.
The $58m two-tranche equity financing brought CardioDx’s total venture funding to $192m. In May 2011, the Palo Alto-based firm closed a $60m venture round that attracted a plethora of investors. J.P. Morgan Partners, JPM’s private equity firm, joined RU-COM’s venture unit Bright Capital, investment partnership Acadia Woods Partners…
